CLINICAL USEFULNESS OF SERUM LEVEL OF ADALIMUMAB, IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引：0
|
作者：
Rosas, J. [1 ]
LLinares, F. [1 ]
de la Torre, I. [2 ]
Valor, L. [2 ]
Barber, X. [3 ]
Santos-Ramirez, C. [4 ]
Hernandez, D. [2 ]
Senabre, J. M. [1 ]
Carreno, L. [2 ]
Santos-Soler, G. [1 ]
Salas, E. [1 ]
Sanchez-BArrioluengo, M. [5 ]
Molina-Garcia, J. [1 ]
机构：
[1] Hosp Marina Baixa, Villajoyosa, Spain
[2] Hosp Univ Gregorio Maranon, Madrid, Spain
[3] Miguel Hernandez Univ, CIO UMH, Elche, Spain
[4] Hosp Marina Alta, Denia, Spain
[5] Univ Politecn Valencia, INGENIO CSIC UPV, E-46071 Valencia, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：233 / 234
页数：2
相关论文
共 50 条
  • [1] Adalimumab Serum Drug Level Correlates to Clinical Response in Patients with Rheumatoid Arthritis
    Opris, Daniela
    Mazilu, Diana
    Bojinca, Violeta
    Balanescu, Andra
    Borangiu, Andreea
    Ionescu, Ruxandra
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S41 - S41
  • [2] ASSOCIATION OF CLINICAL EFFICACY WITH SERUM LEVEL OF ADALIMUMAB (ADA) AND ANTI-ADALIMUMAB ANTIBODY LEVELS IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS (RA)
    Avdeeva, A. S.
    Aleksandrova, E. N.
    Novikov, A. A.
    Karateev, D. E.
    Luchihina, E. L.
    Cherkasova, M. V.
    Nasonov, E. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 927 - 927
  • [3] Clinical relevance of monitoring serum levels of adalimumab in patients with rheumatoid arthritis in daily practice
    Rosas, J.
    Llinares-Tello, F.
    de la Torre, I.
    Santos-Ramirez, C.
    Senabre-Gallego, J. M.
    Valor, L.
    Barber-Valles, X.
    Hernandez-Florez, D.
    Santos-Soler, G.
    Salas-Heredia, E.
    Carreno, L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (06) : 942 - 948
  • [4] Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis
    Bartelds, Geertje M.
    Wijbrandts, Carla A.
    Nurmohamed, Michael T.
    Stapel, Steven
    Lems, Willem F.
    Aarden, Lucien
    Dijkmans, Ben A. C.
    Tak, Paul Peter
    Wolbink, Gerrit Jan
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (07) : 921 - 926
  • [5] Serum Adenosine Deaminase Level in Patients with Rheumatoid Arthritis: Relationship with Clinical Factors
    Borman, Pinar
    Demir, Gulseren
    Ayhan, Figen
    Ozgun, Tuba
    Yilmaz, Gulsen
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S40 - S40
  • [6] PRESENCE OF ANTIBODIES TO ADALIMUMAB AND INFLIXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN CLINICAL REMISSION
    Eng, G.
    Fana, V.
    Omerovic, E.
    Hojsgaard, P.
    Lindegaard, H. M.
    Jensen, E. K.
    Bouchelouche, P. N.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 230 - 230
  • [7] THE SERUM LEVEL OF IRISIN IS DECREASED IN THE PATIENTS WITH RHEUMATOID ARTHRITIS
    Kalkan, A. T.
    Ozmen, M.
    Birlik, B.
    Kozaci, D.
    Turkmen, I.
    Solmaz, D.
    Gercik, O.
    Gucenmez, S.
    Akar, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1170 - 1170
  • [8] ADALIMUMAB SERUM CONCENTRATIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS OR PSORIATIC ARTHRITIS TAKING CONCOMITANT DMARD THERAPY
    Krieckaert, C.
    Vogelzang, E.
    Pouw, M.
    Nurmohamed, M.
    Wolbink, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 157 - 157
  • [9] EVALUATING THE COST-EFFECTIVENESS OF PERSONALIZED TREATMENT WITH ADALIMUMAB USING SERUM DRUG LEVEL AND ANTI-ADALIMUMAB ANTIBODIES IN RHEUMATOID ARTHRITIS PATIENTS
    Krieckaert, C.
    Nair, S. C.
    Nurmohamed, M. T.
    van Dongen, C. J.
    Lems, W. F.
    Lafeber, F. P.
    Bijlsma, J. W.
    Wolbink, G.
    Welsing, P. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 104 - 104
  • [10] ECONOMICAL EVALUATION OF ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Vorobyev, P. A.
    Lesnicheva, M., V
    Avksentyeva, M., V
    Alekseyeva, Y., I
    Karateyev, D. Y.
    VALUE IN HEALTH, 2010, 13 (03) : A126 - A127
12345